Certolizumab Pegol News
Certolizumab Pegol currently has 2 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Certolizumab Pegol with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Rheumatoid arthritis Cimzia, in combination with methotrexate (MTX), is indicated for: the treatment of moderate to severe, active rheumatoid arthritis (RA) in adult patients when the response to...
- Evidence level: L5
- Predicted indications (20):
- ankylosing spondylitis (99.8%)
- rheumatoid vasculitis (99.8%)
- hypermobility of coccyx (99.8%)
- inflammatory spondylopathy (99.7%)
- Kummell disease (99.7%)
- polyarticular juvenile rheumatoid arthritis (99.7%)
- spondyloarthropathy, susceptibility to (99.6%)
- vertebral disease (99.3%)
- rheumatoid arthritis (97.8%)
- mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency (96.8%)
- brachydactyly-syndactyly syndrome (96.0%)
- colobomatous microphthalmia-rhizomelic dysplasia syndrome (95.7%)
- inflammatory bowel disease (95.7%)
- tenosynovitis (95.7%)
- polyp of vocal cord (95.2%)
- polyp of middle ear (95.1%)
- epulis (94.9%)
- polyp of frontal sinus (94.9%)
- polyp of ureter (94.9%)
- polyp of external auditory canal (94.9%)
Related News (2)
A surprisingly simple way to relieve knee arthritis pain without pills or surgery - Science Daily
2026-10-11 arthritis
Source: Science Daily
Knee pain and crunching: 3 exercises to ease osteoarthritis of the kneecap - South China Morning Post
2026-10-09 arthritis
Source: South China Morning Post
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.